The Effects of Multimodal Prehabilitation Interventions in Men Affected by Prostate Cancer on Physical, Clinical and Patient Reported Outcome Measures: A Systematic Review.


Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 24 8 2022
medline: 26 10 2022
entrez: 23 8 2022
Statut: ppublish

Résumé

To synthesize existing evidence on the effects of multimodal prehabilitation interventions in men affected by prostate cancer on physical, clinical, and patient-reported outcome measures. A systematic review was conducted according to the PRISMA 2020 Statement Guidelines. Electronic databases (ie, Medline, Embase, CINAHL and Cochrane CENTRAL, and clinicaltrials.gov) were searched using key search terms. Articles were assessed according to prespecified eligibility criteria. Data extraction and quality appraisal was conducted. The findings were integrated in a narrative synthesis. Of the 5863 publications screened, 118 articles were assessed in full text and 17 studies met the prescreening eligibility criteria. There were a range of study designs that included randomized controlled clinical trials (n = 11), quasi experimental (n = 4), cohort (n = 1), and case series (n = 1), covering a total of 1739 participants. The prehabilitation interventions included physical activity, peer support, pelvic floor muscle training, diet, nurse-led prehabilitation, psychological, and prehabilitation administration of phosphodiesterase-5 inhibitors. Significant heterogeneity existed in the prehabilitation intervention programs for men affected by prostate cancer in terms of the composition, duration, method of administration, and the outcomes measured to quantify their impact. This systematic review has identified that multimodal prehabilitation interventions are an emerging area for practice and research among men affected by prostate cancer. Importantly, there has been a lack of focus on the inclusion of partners as critical companions during this distressing phase of the cancer care continuum. For the moment, all members of the multidisciplinary team caring for people affected by prostate cancer are encouraged to use the findings in this review to inform holistic models of care.

Identifiants

pubmed: 35999090
pii: S0749-2081(22)00106-1
doi: 10.1016/j.soncn.2022.151333
pii:
doi:

Substances chimiques

Cyclic Nucleotide Phosphodiesterases, Type 5 EC 3.1.4.35

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151333

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Catherine Paterson (C)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia; Canberra Health Services & ACT Health, SYNERGY Nursing & Midwifery Research Centre, ACT Health Directorate Level 3, Canberra Hospital, Canberra, Australia; Robert Gordon University, Aberdeen, Scotland, UK. Electronic address: catherine.paterson@canberra.edu.au.

Cara Roberts (C)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Maria Kozlovskaia (M)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Irmina Nahon (I)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Kathryn Schubach (K)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Sally Sara (S)

Prostate Cancer Foundation of Australia, Sydney, Australia; School of Nursing & Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia.

Alesha M Sayner (AM)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia; Grampians Health, Allied Health department, Ballarat, Victoria, Australia.

Richard De Abreu Lourenco (R)

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia.

Murray Turner (M)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Raymond J Chan (RJ)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.

Thomas Lam (T)

Academic Urology Unit, Aberdeen University, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.

Henry Woo (H)

College of Health and Medicine, Australian National University, Canberra, ACT, Australia; Department of Uro-Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; SAN Prostate Centre of Excellence, Sydney Adventist Hospital. Wahroonga, NSW, Australia.

Kellie Toohey (K)

Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, Faculty of Health, University of Canberra, Bruce ACT, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH